A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% fewer pauses in breathing and improved oxygen levels during sleep. The drug helps stabilize breathing signals in the brain, reducing airway collapse. Scientists say the findings could pave the way for a pill-based alternative to CPAP machines.
Quelle: ScienceDaily | Asthma
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Asthma
- Scientists may have found a pill for sleep apnea
- Simple blood test can forecast Alzheimer’s years before memory loss
- A hidden breathing problem may be behind chronic fatigue’s crushing exhaustion
- COVID vaccine linked to fewer infections and allergies in kids with eczema
- Doctors tested a common drug on COVID. The results are stunning
- New inhaler halves childhood asthma attacks
- One number at age 7 could predict how long you live
- More likely to be struck by lightning than get tetanus. So why the boosters?
- Invisible ID: How a single breath could reveal your health—and your identity
- People with critical cardiovascular disease may benefit from palliative care
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
